![Nishant Saxena](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 698 763 $ au 31/07/2026
Nishant Saxena is currently Chief Business Officer at Corbus Pharmaceuticals Holdings, Inc. since 2026.
Formerly, Mr. Saxena was Chief Financial Officer at Jeune Aesthetics, Inc. Education includes undergraduate and MBA degrees from The Wharton School of the University of Pennsylvania.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/08/2026 | 77 900 ( 0,42 % ) | 698 763 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Corporate Officer/Principal | 21/05/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
Jeune Aesthetics, Inc.
 Jeune Aesthetics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur Financier/CFO | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corbus Pharmaceuticals Holdings, Inc.
 Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
Jeune Aesthetics, Inc.
Jeune Aesthetics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
